Stocktoria

AMGEN INC AMGN

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 1983-06-17 · LEI

AMGEN INC financials (annual)

Revenue
$22.99B $22.85B $23.75B $23.36B $25.42B $25.98B $26.32B $28.19B $33.42B $36.75B 2016201720182019202020212022202320242025
Net income
$7.72B $1.98B $8.39B $7.84B $7.26B $5.89B $6.55B $6.72B $4.09B $7.71B 2016201720182019202020212022202320242025
Free cash flow
$9.62B $10.51B $10.56B $8.53B $9.89B $8.38B $8.79B $7.36B $10.39B $8.10B 2016201720182019202020212022202320242025

Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$36.8B$33.4B$28.2B$26.3B$26.0B$25.4B$23.4B$23.7B$22.8B$23.0B
SG&A expense$7.0B$7.1B$6.2B$5.4B$5.4B$5.7B$5.2B$5.3B$4.9B$5.1B
Operating income$9.1B$7.3B$7.9B$9.6B$7.6B$9.1B$9.7B$10.3B$10.0B$9.8B
Income tax$1.3B$519.0M$1.1B$794.0M$808.0M$869.0M$1.3B$1.2B$7.6B$1.4B
Net income$7.7B$4.1B$6.7B$6.6B$5.9B$7.3B$7.8B$8.4B$2.0B$7.7B
EPS (diluted)$14.23$7.56$12.49$12.11$10.28$12.31$12.88$12.62$2.69$10.24
Operating cash flow$10.0B$11.5B$8.5B$9.7B$9.3B$10.5B$9.2B$11.3B$11.2B$10.4B
Free cash flow$8.1B$10.4B$7.4B$8.8B$8.4B$9.9B$8.5B$10.6B$10.5B$9.6B
Cash & equivalents$9.1B$12.0B$10.9B$7.6B$8.0B$6.3B$6.0B$6.9B$3.8B$3.2B
Inventory$6.2B$7.0B$9.5B$4.9B$4.1B$3.9B$3.6B$2.9B$2.8B$2.7B
Total assets$90.6B$91.8B$97.2B$65.1B$61.2B$62.9B$59.7B$66.4B$80.0B$77.6B
Shareholders' equity$8.7B$5.9B$6.2B$3.7B$6.7B$9.4B$9.7B$12.5B$25.2B$29.9B

Growth · year-over-year · Revenue CAGR 5.4%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue growth+10.0%+18.6%+7.1%+1.3%+2.2%+8.8%-1.6%+3.9%-0.6%+6.1%
Net income growth+88.5%-39.1%+2.5%+11.2%-18.9%-7.4%-6.6%+324.2%-74.4%+11.3%
EPS growth+88.2%-39.5%+3.1%+17.8%-16.5%-4.4%+2.1%+369.1%-73.7%+13.0%
Free cash flow growth-22.1%+41.2%-16.2%+4.8%-15.2%+15.9%-19.2%+0.4%+9.3%+5.2%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.